RIVM Rapport 260401006 systolic dysfunction complicating myocardial infarction: the VALIANT registry. Eur Heart J 25, 1911-9. Verdecchia P, Angeli F, Cavallini C, Gattobigio R, G<strong>en</strong>tile G, Staess<strong>en</strong> JA, Reboldi G (2009). Blood pressure reduction and r<strong>en</strong>in-angiot<strong>en</strong>sin system inhibition for prev<strong>en</strong>tion of congestive heart failure: a meta-analysis. Eur Heart J 30, 679-88. Wachtell K, Smith G, Gerdts E, Dahlof B, Niemin<strong>en</strong> MS, Papademetriou V, Bella JN, Ibs<strong>en</strong> H, Rokkedal J, Devereux RB (2000). Left v<strong>en</strong>tricular filling patterns in pati<strong>en</strong>ts with systemic hypert<strong>en</strong>sion and left v<strong>en</strong>tricular hypertrophy (the LIFE study). Losartan Interv<strong>en</strong>tion For Endpoint. Am J Cardiol 85, 466-72. Wachtell K, Rokkedal J, Bella JN, Aalto T, Dahlof B, Smith G, Roman MJ, Ibs<strong>en</strong> H, Aurigemma GP, Devereux RB (2001). Effect of electrocardiographic left v<strong>en</strong>tricular hypertrophy on left v<strong>en</strong>tricular systolic function in systemic hypert<strong>en</strong>sion (The LIFE Study). Losartan Interv<strong>en</strong>tion For Endpoint. Am J Cardiol 87, 54-60. Wachtell K, Bella JN, Rokkedal J, Palmieri V, Papademetriou V, Dahlöf B, Aalto T, Gerdts E, Devereux RB (2002a). Change in diastolic left v<strong>en</strong>tricular filling after one year of antihypert<strong>en</strong>sive treatm<strong>en</strong>t: the Losartan Interv<strong>en</strong>tion For Endpoint Reduction in Hypert<strong>en</strong>sion (LIFE) Study. Circulation 105:1071– 1076. Wachtell K, Palmieri V, Ols<strong>en</strong> MH, Gerdts E, Papademetriou V, Niemin<strong>en</strong> MS, Smith G, Dahlof B, Aurigemma GP, Devereux RB (2002b). Change in systolic left v<strong>en</strong>tricular performance after 3 years of antihypert<strong>en</strong>sive treatm<strong>en</strong>t: the Losartan Interv<strong>en</strong>tion for Endpoint (LIFE) Study. Circulation 106, 227-32. Wachtell K, Papademetriou V, Smith G, Gerdts E, Dahlof B, Engblom E, Aurigemma GP, Bella JN, Ibs<strong>en</strong> H, Rokkedal J, Devereux RB (2004). Relation of impaired left v<strong>en</strong>tricular filling to systolic midwall mechanics in hypert<strong>en</strong>sive pati<strong>en</strong>ts with normal left v<strong>en</strong>tricular systolic chamber function: the Losartan Interv<strong>en</strong>tion for Endpoint Reduction in Hypert<strong>en</strong>sion (LIFE) study. Am Heart J 148, 538-44. Wang TJ, Evans JC, B<strong>en</strong>jamin EJ, Levy D, Leroy EC, Vasan RS (2003a). Natural history of asymptomatic left v<strong>en</strong>tricular systolic dysfunction in the community. Circulation 108, 977-82. Wang TJ, Levy D, B<strong>en</strong>jamin EJ, Vasan RS (2003b). The epidemiology of "asymptomatic" left v<strong>en</strong>tricular systolic dysfunction: implications for scre<strong>en</strong>ing. Ann Intern Med 138, 907-16. Wang TJ, Larson MG, Levy D, B<strong>en</strong>jamin EJ, Leip EP, Omland T, Wolf PA, Vasan RS (2004). Plasma natriuretic peptide levels and the risk of cardiovascular ev<strong>en</strong>ts and death. N Engl J Med 350, 655-63. Wang Y, Tuomilehto J, Jousilahti P, Antikain<strong>en</strong> R, Mahon<strong>en</strong> M, Katzmarzyk PT, Hu G (2010). Occupational, commuting, and leisure-time physical activity in relation to heart failure among finnish m<strong>en</strong> and wom<strong>en</strong>. J Am Coll Cardiol 56, 1140-8. Watson CJ, Ledwidge MT, Phelan D, Collier P, Byrne JC, Dunn MJ, Mcdonald KM, Baugh JA (2011). Proteomic analysis of coronary sinus serum reveals leucinerich alpha2-glycoprotein as a novel biomarker of v<strong>en</strong>tricular dysfunction and heart failure. Circ Heart Fail 4, 188-97. W<strong>en</strong>del-Vos GCW, Ooij<strong>en</strong>dijk WTM, van Baal PHM, Storm I, Vijg<strong>en</strong> SMC, Jans M, Hopman-Rock M, Schuit AJ, de Wit GA, Bemelmans WJE (2005). Kost<strong>en</strong>effectiviteit <strong>en</strong> gezondheidswinst van behal<strong>en</strong> beleidsdoel<strong>en</strong> beweg<strong>en</strong> <strong>en</strong> overgewicht. Onderbouwing Nationaal Actieplan Sport <strong>en</strong> Beweg<strong>en</strong>. RIVMrapport 260701001. Bilthov<strong>en</strong>. Wijeysundera HC, Machado M, Farahati F, Wang X, Witteman W, Van Der Velde G, Tu JV, Lee DS, Goodman SG, Petrella R, O'flaherty M, Krahn M, Capewell S Pagina 115 van 122
RIVM Rapport 260401006 (2010). Association of temporal tr<strong>en</strong>ds in risk factors and treatm<strong>en</strong>t uptake with coronary heart disease mortality, 1994-2005. JAMA 303, 1841-7. Wilhelms<strong>en</strong> L, Ros<strong>en</strong>gr<strong>en</strong> A, Eriksson H, Lappas G (2001). Heart failure in the g<strong>en</strong>eral population of m<strong>en</strong>--morbidity, risk factors and prognosis. J Intern Med 249, 253-61. Williams B, Lacy PS (2010). C<strong>en</strong>tral haemodynamics and clinical outcomes: going beyond brachial blood pressure? Eur Heart J 31, 1819-22. Wilson PW, D'agostino RB, Sullivan L, Parise H, Kannel WB (2002). Overweight and obesity as determinants of cardiovascular risk: the Framingham experi<strong>en</strong>ce. Arch Intern Med 162, 1867-72. Yan AT, Yan RT, Cushman M, Redheuil A, Tracy RP, Arnett DK, Ros<strong>en</strong> BD, Mcclelland RL, Bluemke DA, Lima JA (2010). Relationship of interleukin-6 with regional and global left-v<strong>en</strong>tricular function in asymptomatic individuals without clinical cardiovascular disease: insights from the Multi-Ethnic Study of Atherosclerosis. Eur Heart J 31, 875-82. Yan RT, Fernandes V, Yan AT, Cushman M, Redheuil A, Tracy R, Vogel-Clauss<strong>en</strong> J, Bahrami H, Nasir K, Bluemke DA, Lima JA (2010). Fibrinog<strong>en</strong> and left v<strong>en</strong>tricular myocardial systolic function: The Multi-Ethnic Study of Atherosclerosis (MESA). Am Heart J 160, 479-86. Yeh RW, Go AS (2010a). Rethinking the epidemiology of acute myocardial infarction: chall<strong>en</strong>ges and opportunities. Arch Intern Med 170(9): 759-64. Yeh RW, Sidney S (2010b). Population tr<strong>en</strong>ds in the incid<strong>en</strong>ce and outcomes of acute myocardial infarction. N Eng J Med 362(23): 2155-65. Zeijl E, Crone M, Wiefferink K, Keuz<strong>en</strong>kamp S, Reijneveld M (2005). Kinder<strong>en</strong> in Nederland. SCP, Sociaal Cultuur Planbureau, D<strong>en</strong> Haag. Pagina 116 van 122